120 related articles for article (PubMed ID: 19462899)
1. [A study on anticancer activity of tanshinone II A against human breast cancer].
Zhang PR; Lü Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):245-9. PubMed ID: 19462899
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
[TBL] [Abstract][Full Text] [Related]
3. [Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative].
Jing J; Zheng H; Wang J; Lin P; Zhang J; Xiong ZJ; Wu YY; Ren JJ; Yang HL; Wang XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):391-5. PubMed ID: 17593814
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios.
Su CC; Lin YH
Int J Mol Med; 2008 Sep; 22(3):357-61. PubMed ID: 18698495
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of cell growth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione IIA].
Zhong ZH; Chen WG; Liu YH; Li QX; Qiu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):99-103. PubMed ID: 17344596
[TBL] [Abstract][Full Text] [Related]
9. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
He FJ; Wang J; Niu JZ; Wang JF
Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of proliferation and induction of apoptosis by tanshinone II A in NCI-H460 cell].
Hu H; Zhang Y; Huang F; Deng H
Zhong Yao Cai; 2005 Apr; 28(4):301-4. PubMed ID: 16104505
[TBL] [Abstract][Full Text] [Related]
11. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
12. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
[TBL] [Abstract][Full Text] [Related]
13. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
15. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
16. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.
Zhang M; Chiu LC; Cheung PC; Ooi VE
Oncol Rep; 2006 Mar; 15(3):637-43. PubMed ID: 16465424
[TBL] [Abstract][Full Text] [Related]
17. Potential anticancer activity of tanshinone IIA against human breast cancer.
Wang X; Wei Y; Yuan S; Liu G; Lu Y; Zhang J; Wang W
Int J Cancer; 2005 Sep; 116(5):799-807. PubMed ID: 15849732
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells.
Choi EJ; Bae SM; Ahn WS
Arch Pharm Res; 2008 Oct; 31(10):1281-5. PubMed ID: 18958418
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
[TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
